A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)
Clinical trial NCT04612725 · TERMINATED
Trial details
- NCT number
- NCT04612725
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2022-10-13
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.